CorMedix Stock (NASDAQ:CRMD)


Chart

Previous Close

$11.27

52W Range

$5.60 - $17.43

50D Avg

$12.25

200D Avg

$11.08

Market Cap

$821.07M

Avg Vol (3M)

$3.33M

Beta

1.85

Div Yield

-

CRMD Company Profile


CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

64

IPO Date

May 13, 2010

Website

CRMD Performance


Latest Earnings Call Transcripts


Q2 22Aug 11, 22 | 2:36 PM
Q1 22May 12, 22 | 8:45 PM
Q4 21Mar 29, 22 | 9:44 PM

Peer Comparison


TickerCompany
VTVTvTv Therapeutics Inc.
TLPHTalphera, Inc.
VRCAVerrica Pharmaceuticals Inc.
FENCFennec Pharmaceuticals Inc.
BPTHBio-Path Holdings, Inc.
TickerGate Footer Logo

Tickergate is an advanced stock research & comparison platform for informed data-driven investment decisions. 100% customizable, institutional-grade data, easy to use.

Company

AboutContact

Connect

LinkedIn

©2025 Tickergate

Tickergate does not provide financial advices and does not issue recommendations or offers to buy stocks of sell any securities. Information is provided 'as-is' and solely for informational purposes as an advice. Tickergate does not bear any responsibility or any losses or damages that may occur as a result of reliance on this data.
Start a conversation

Ask me anything about stocks, markets, or financial data.

Market Trends
Compare Stocks